drugset / Trial / NCT03501680

Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis.

NCT03501680

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to investigate the therapeutic efficacy of intensive insulin in patients with hypertriglyceridemia induced moderate/severe acute pancreatitis on the course and outcome of disease.

Timeline

Start
2018-06-06
Primary completion
2020-03-08
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Other